CFO
CORZ icon

CVA Family Office’s Core Scientific CORZ Stock Holding History

CVA Family Office’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61K Buy
+102
New +$2.4K ﹤0.01% 1466

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

CVA Family Office's CORZ Position: Q2 2026 in Review

CVA Family Office opened a new position in Core Scientific (CORZ) in Q2 2026: 102 shares worth $2.61K. The stake represents ﹤0.01% of the portfolio and ranks #1466 among its holdings.

412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • CVA Family Office held 102 shares of Core Scientific worth $2.61K as of Q2 2026.
  • Core Scientific was a new CVA Family Office position in Q2 2026.
  • Core Scientific made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1466 holding.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.